Macitentan
Macitentan is a pharmaceutical drug with 29 clinical trials. Currently 1 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 20 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
6
Mid Stage
16
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
71.4%
20 of 28 finished
28.6%
8 ended early
1
trials recruiting
29
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)
A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension
A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
Clinical Trials (29)
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)
A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension
A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
Clinical Study to Investigate the Effect of Macitentan on the Concentrations of Rosuvastatin in the Blood of Healthy Male Subjects
A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.
A 2-part Study to Investigate the Effect of Macitentan in Healthy Male Participants
Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH
A Study of Two Different Test Formulations Compared to the Reference Formulation of Macitentan in Healthy Adult Participants
A Study of Two Macitentan Formulations in Healthy Adult Participants
Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
A Study of Two Macitentan Pediatric Formulations in Healthy Adult Participants
REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension
PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants
A Study of Macitentan in Children Below 2 Years of Age
Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 29